"Harvard Cancer Institute Retracts 6 Papers, Corrects 31 Amid Data Manipulation Claims"
TL;DR Summary
The Dana-Farber Cancer Institute is retracting six papers and correcting 31 others authored by four senior researchers following allegations of data manipulation. The corrections come after claims of misconduct against DFCI President and CEO Laurie H. Glimcher ’72, Executive Vice President and COO William C. Hahn ’87, Senior Vice President for Experimental Medicine Irene M. Ghobrial, and Harvard Medical School professor Kenneth C. Anderson. The institute's research integrity officer stated that they are committed to a culture of accountability and integrity and are examining every inquiry about research integrity fully.
Topics:world#dana-farber-cancer-institute#data-manipulation#research-integrity#retractions#science#scientific-misconduct
- Dana-Farber to Retract 6 Papers, Correct 31 Following Data Manipulation Claims | News Harvard Crimson
- Top Cancer Center Seeks to Retract or Correct Dozens of Studies The New York Times
- Harvard Teaching Hospital Seeks Retraction of Six Papers by Top Researchers The Wall Street Journal
- Harvard teaching hospital to retract papers by top researchers following data falsification probe New York Post
- Harvard cancer institute moves to retract six studies, correct 31 others amid data manipulation claims CNN
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
75%
357 → 90 words
Want the full story? Read the original article
Read on Harvard Crimson